Inhibition of glycogen synthase kinase-3 enhances the differentiation and reduces the proliferation of adult human olfactory epithelium neural precursors

Experimental Cell Research

Volumn 317, Issue 15, 2011, Pages 2086-2098

  Manceur, Aziza P ^a,b   Tseng, Michael ^b,c   Holowacz, Tamara ^b   Witterick, Ian ^b,c   Weksberg, Rosanna ^b,d   McCurdy, Richard D ^d,e   Warsh, Jerry J ^b,c   Audet, Julie ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Differentiation; GSK 3; Olfactory mucosa; Stem cell; TAT(47 57)

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3;

ADULT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; OLFACTORY EPITHELIUM; PRIORITY JOURNAL;

MURINAE;

EID: 79960835809     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.06.004     Document Type: Article

References (64)

1. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
2. Coles-Takabe B.L., Brain I., Purpura K.A., Karpowicz P., Zandstra P.W., Morshead C.M., van der Kooy D. Don't look: growing clonal versus nonclonal neural stem cell colonies. Stem Cells 2008, 26:2938-2944.
3. Graziadei P.P.C., Monti Graziadei G.A. The olfactory system: a model for the study of neurogenesis and axon regeneration in mammals. Neuronal Plasticity 1978, 131-153. Raven Press, New York. C.W. Cotman (Ed.).
4. Mackay-Sim A., Kittel P. Cell dynamics in the adult mouse olfactory epithelium: a quantitative autoradiographic study. J. Neurosci. 1991, 11:979-984.
5. Calof A.L., Mumm J.S., Rim P.C., Shou J. The neuronal stem cell of the olfactory epithelium. J. Neurobiol. 1998, 36:190-205.
6. Murrell W., Feron F., Wetzig A., Cameron N., Splatt K., Bellette B., Bianco J., Perry C., Lee G., Mackay-Sim A. Multipotent stem cells from adult olfactory mucosa. Dev. Dyn. 2005, 233:496-515.
7. Ronnett G.V., Leopold D., Cai X., Hoffbuhr K.C., Moses L., Hoffman E.P., Naidu S. Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome. Ann. Neurol. 2003, 54:206-218.
8. Matigian N., Abrahamsen G., Sutharsan R., Cook A.L., Vitale A.M., Nouwens A., Bellette B., An J., Anderson M., Beckhouse A.G., Bennebroek M., Cecil R., Chalk A.M., Cochrane J., Fan Y., Feron F., McCurdy R., McGrath J.J., Murrell W., Perry C., Raju J., Ravishankar S., Silburn P.A., Sutherland G.T., Mahler S., Mellick G.D., Wood S.A., Sue C.M., Wells C.A., Mackay-Sim A. Disease-specific, neurosphere-derived cells as models for brain disorders. Dis. Model. Mech. 2010, 3:785-798.
9. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. U. S. A. 1996, 93:8455-8459.
10. Jope R.S., Roh M.S. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr. Drug Targets 2006, 7:1421-1434.
11. Benedetti F., Serretti A., Pontiggia A., Bernasconi A., Lorenzi C., Colombo C., Smeraldi E. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50T/C SNP. Neurosci. Lett. 2005, 376:51-55.
12. Benedetti F., Poletti S., Radaelli D., Bernasconi A., Cavallaro R., Falini A., Lorenzi C., Pirovano A., Dallaspezia S., Locatelli C., Scotti G., Smeraldi E. Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-beta activity. Genes Brain Behav. 2010, 9:365-371.
13. Gould T.D., Manji H.K. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 2005, 30:1223-1237.
14. Beaulieu J.M., Gainetdinov R.R., Caron M.G. Akt/GSK3 signaling in the action of psychotropic drugs. Annu. Rev. Pharmacol. Toxicol. 2009, 49:327-347.
15. Lamont E.W., Coutu D.L., Cermakian N., Boivin D.B. Circadian rhythms and clock genes in psychotic disorders. Isr. J. Psychiatry Relat. Sci. 2010, 47:27-35.
16. Kozlovsky N., Belmaker R.H., Agam G. Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am. J. Psychiatry 2000, 157:831-833.
17. Kozlovsky N., Belmaker R.H., Agam G. Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizophr. Res. 2001, 52:101-105.
18. Kozlovsky N., Regenold W.T., Levine J., Rapoport A., Belmaker R.H., Agam G. GSK-3beta in cerebrospinal fluid of schizophrenia patients. J. Neural Transm. 2004, 111:1093-1098.
19. Maurer M.H., Bromme J.O., Feldmann R.E., Jarve A., Sabouri F., Burgers H.F., Schelshorn D.W., Kruger C., Schneider A., Kuschinsky W. Glycogen synthase kinase 3beta (GSK3beta) regulates differentiation and proliferation in neural stem cells from the rat subventricular zone. J. Proteome Res. 2007, 6:1198-1208.
20. Bain J., McLauchlan H., Elliott M., Cohen P. The specificities of protein kinase inhibitors: an update. Biochem. J. 2003, 371:199-204.
21. Allsopp T.E., Bunnage M.E., Fish P.V. Small molecule modulation of stem cells in regenerative medicine: recent applications and future direction. Med. Chem. Commun. 2010, 1:16-29.
22. Manceur A.P., Driscoll B.D., Sun W., Audet J. Selective enhancement of the uptake and bioactivity of a TAT-conjugated peptide inhibitor of glycogen synthase kinase-3. Mol. Ther. 2009, 17:500-507.
23. Li W., Zhou H., Abujarour R., Zhu S., Young Joo J., Lin T., Hao E., Scholer H.R., Hayek A., Ding S. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 2009, 27:2992-3000.
24. Bone H.K., Damiano T., Bartlett S., Perry A., Letchford J., Ripoll Y.S., Nelson A.S., Welham M.J. Involvement of GSK-3 in regulation of murine embryonic stem cell self-renewal revealed by a series of bisindolylmaleimides. Chem. Biol. 2009, 16:15-27.
25. Meijer L., Flajolet M., Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol. Sci. 2004, 25:471-480.
26. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315.
27. Kaidanovich-Beilin O., Eldar-Finkelman H. Peptides targeting protein kinases: strategies and implications. Physiology (Bethesda) 2006, 21:411-418.
28. Welsh G.I., Patel J.C., Proud C.G. Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts. Anal. Biochem. 1997, 244:16-21.
29. Bennett C.N., Ross S.E., Longo K.A., Bajnok L., Hemati N., Johnson K.W., Harrison S.D., MacDougald O.A. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 2002, 277:30998-31004.
30. Sato N., Meijer L., Skaltsounis L., Greengard P., Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 2004, 10:55-63.
31. Doble B.W., Patel S., Wood G.A., Kockeritz L.K., Woodgett J.R. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell 2007, 12:957-971.
32. Fok E.Y., Zandstra P.W. Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells 2005, 23:1333-1342.
33. McCurdy R.D., Feron F., Perry C., Chant D.C., McLean D., Matigian N., Hayward N.K., McGrath J.J., Mackay-Sim A. Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr. Res. 2006, 82:163-173.
34. McCurdy R., Witterick I., Lin D., Weksberg R., Chow E., Bassett A. Applying an olfactory neuroepithelial model of neurodevelopment to familial schizophrenia. Schizophr. Bull. 2007, 33:301.
35. Zhang X., Klueber K.M., Guo Z., Lu C., Roisen F.J. Adult human olfactory neural progenitors cultured in defined medium. Exp. Neurol. 2004, 186:112-123.
36. Roisen F.J., Klueber K.M., Lu C.L., Hatcher L.M., Dozier A., Shields C.B., Maguire S. Adult human olfactory stem cells. Brain Res. 2001, 890:11-22.
37. Murrell W., Wetzig A., Donnellan M., Feron F., Burne T., Meedeniya A., Kesby J., Bianco J., Perry C., Silburn P., Mackay-Sim A. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease. Stem Cells 2008, 26:2183-2192.
38. Murrell W., Sanford E., Anderberg L., Cavanagh B., Mackay-Sim A. Olfactory stem cells can be induced to express chondrogenic phenotype in a rat intervertebral disc injury model. Spine J. 2009, 9:585-594.
39. Ryves W.J., Fryer L., Dale T., Harwood A.J. An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts. Anal. Biochem. 1998, 264:124-127.
40. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
41. Manceur A., Wu A., Audet J. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells. Anal. Biochem. 2007, 364:51-59.
42. Hur E.M., Zhou F.Q. GSK3 signalling in neural development. Nature reviews. Neuroscience 2010, 11:539-551.
43. Trowbridge J.J., Xenocostas A., Moon R.T., Bhatia M. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat. Med. 2006, 12:89-98.
44. Inoue T., Kagawa T., Fukushima M., Shimizu T., Yoshinaga Y., Takada S., Tanihara H., Taga T. Activation of canonical Wnt pathway promotes proliferation of retinal stem cells derived from adult mouse ciliary margin. Stem Cells 2006, 24:95-104.
45. Ling L., Nurcombe V., Cool S.M. Wnt signaling controls the fate of mesenchymal stem cells. Gene 2009, 433:1-7.
46. Gattinoni L., Zhong X.S., Palmer D.C., Ji Y., Hinrichs C.S., Yu Z., Wrzesinski C., Boni A., Cassard L., Garvin L.M., Paulos C.M., Muranski P., Restifo N.P. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat. Med. 2009, 15:808-813.
47. Kim W.Y., Wang X., Wu Y., Doble B.W., Patel S., Woodgett J.R., Snider W.D. GSK-3 is a master regulator of neural progenitor homeostasis. Nat. Neurosci. 2009, 12:1390-1397.
48. Cajanek L., Ribeiro D., Liste I., Parish C.L., Bryja V., Arenas E. Wnt/beta-catenin signaling blockade promotes neuronal induction and dopaminergic differentiation in embryonic stem cells. Stem Cells 2009, 27:2917-2927.
49. Davidson K.C., Jamshidi P., Daly R., Hearn M.T., Pera M.F., Dottori M. Wnt3a regulates survival, expansion, and maintenance of neural progenitors derived from human embryonic stem cells. Mol. Cell. Neurosci. 2007, 36:408-415.
50. Booker-Dwyer T., Hirsh S., Zhao H. A unique cell population in the mouse olfactory bulb displays nuclear beta-catenin signaling during development and olfactory sensory neuron regeneration. Dev. Neurobiol. 2008, 68:859-869.
51. Maretto S., Cordenonsi M., Dupont S., Braghetta P., Broccoli V., Hassan A.B., Volpin D., Bressan G.M., Piccolo S. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc. Natl Acad. Sci. U. S. A. 2003, 100:3299-3304.
52. Hirabayashi Y., Itoh Y., Tabata H., Nakajima K., Akiyama T., Masuyama N., Gotoh Y. The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells. Development 2004, 131:2791-2801.
53. Kuwahara A., Hirabayashi Y., Knoepfler P.S., Taketo M.M., Sakai J., Kodama T., Gotoh Y. Wnt signaling and its downstream target N-myc regulate basal progenitors in the developing neocortex. Development 2010, 137:1035-1044.
54. Castelo-Branco G., Rawal N., Arenas E. GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J. Cell Sci. 2004, 117:5731-5737.
55. Shimizu T., Kagawa T., Inoue T., Nonaka A., Takada S., Aburatani H., Taga T. Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells. Mol. Cell. Biol. 2008, 28:7427-7441.
56. Chenn A., Walsh C.A. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 2002, 297:365-369.
57. Megason S.G., McMahon A.P. A mitogen gradient of dorsal midline Wnts organizes growth in the CNS. Development 2002, 129:2087-2098.
58. Viti J., Gulacsi A., Lillien L. Wnt regulation of progenitor maturation in the cortex depends on Shh or fibroblast growth factor 2. J. Neurosci. 2003, 23:5919-5927.
59. Henrique D., Bally-Cuif L. A cross-disciplinary approach to understanding neural stem cells in development and disease. Development 2010, 137:1933-1938.
60. Feron F., Vincent A., Mackay-Sim A. Dopamine promotes differentiation of olfactory neuron in vitro. Brain Res. 1999, 845:252-259.
61. McCurdy R.D., Feron F., McGrath J.J., Mackay-Sim A. Regulation of adult olfactory neurogenesis by insulin-like growth factor-I. Eur. J. Neurosci. 2005, 22:1581-1588.
62. Sulz L., Astorga G., Bellette B., Iturriaga R., Mackay-Sim A., Bacigalupo J. Nitric oxide regulates neurogenesis in adult olfactory epithelium in vitro. Nitric Oxide 2009, 20:238-252.
63. Zhang X., Klueber K.M., Guo Z., Cai J., Lu C., Winstead W.I., Qiu M., Roisen F.J. Induction of neuronal differentiation of adult human olfactory neuroepithelial-derived progenitors. Brain Res. 2006, 1073-1074:109-119.
64. Lu J., Feron F., Ho S.M., Mackay-Sim A., Waite P.M. Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res. 2001, 889:344-357.